IP Library Granted Patent US 12686698
Granted Patent B2
US 12686698 · App. 17/681,731 · Granted Jul 21, 2026

Fast deprotecting n-exocyclic amino cyclic hydrocarbon protected groups for nucleoside phosphoramidites

Inventors: Benjamin D. Lunstad (Boulder, CA); Douglas J. Dellinger (Boulder, CA); Robert Kaiser (Santa Clara, CA)
Assignee: AGILENT TECHNOLOGIES, INC.
C07H23/00C07H19/16C07H19/207C07H21/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12686698
App. No.
17/681,731
Granted
Jul 21, 2026
Kind
B2
Abstract

Compounds useful for forming nucleic acids having the structure of Formula I: Each of R 1 or R 2 is independently selected from hydrogen, a protecting group, or a phosphoramidite group. R 3 is selected from H, F, O—C 1-6 alkyl, O-MOE and a removable hydroxyl-protecting group. Q is a heterocyclic base. R 4 is a cyclic hydrocarbon. Also disclosed are processes for forming the nucleic acids from the compounds and the nucleic acid products produced.

Claims (41)

1 . A compound having the structure of Formula I:

wherein each of R 1 or R 2 is independently selected from the group consisting of a protecting group and a phosphoramidite group, provided R 1 and R 2 are not both protecting groups;

wherein R 3 is H, F, O—C 1-6 alkyl, O-MOE, or O-thiocarbon protecting group;

wherein Q is a heterocyclic base; and

wherein R 4 is cyclopentyl or cyclohexyl.

2 . The compound according to claim 1 , wherein said compound has the structure of Formula Ia:

wherein each of R 1 or R 2 is independently selected from the group consisting of a protecting group and a phosphoramidite group, provided R 1 and R 2 are not both protecting groups;

wherein R 3 is H, F, O—C 1-6 alkyl, O-MOE, or O-thiocarbon protecting group; and

wherein R 4 is cyclopentyl or cyclohexyl.

3 . The compound according to claim 2 , wherein R 1 and R 2 are each independently selected from 4,4′-dimethoxytrityl (DMT) and 2-cyanoethyl-(N,N-diisopropylamino)-phosphoramidite.

4 . The compound according to claim 3 , wherein R 4 is cyclopentyl and wherein R 3 is O-TC:

5 . The compound according to claim 1 , wherein said compound has the structure of Formula Ib:

wherein each of R 1 or R 2 is independently selected from the group consisting of a protecting group and a phosphoramidite group, provided R 1 and R 2 are not both protecting groups;

wherein R 3 is H, F, O—C 1-6 alkyl, O-MOE, or O-thiocarbon protecting group; and

wherein R 4 is cyclopentyl or cyclohexyl.

6 . The compound according to claim 5 , wherein R 1 and R 2 are each independently selected from 4,4′-dimethoxytrityl (DMT) and 2-cyanoethyl-(N,N-diisopropylamino)-phosphoramidite.

7 . The compound according to claim 6 , wherein R 4 is cyclopentyl and wherein R 3 is O-TC:

8 . A method comprising:

contacting a nucleoside residue comprising a 5′ or 3′ unprotected hydroxyl with a protected nucleotide monomer having the structure of Formula I:

wherein each of R 1 or R 2 is independently selected from the group consisting of a protecting group and a phosphoramidite group, provided R 1 and R 2 are not both protecting groups;

wherein R 3 is H, F, O—C 1-6 alkyl, O-MOE or O-thiocarbon protecting group;

wherein Q is a heterocyclic base; and

wherein R 4 is cyclopentyl or cyclohexyl,

under conditions sufficient to covalently bond said phosphoramidite group of said protected nucleotide monomer to said unprotected hydroxyl group of said nucleoside residue and produce an internucleotide bond.

9 . The method according to claim 8 , wherein said method further comprises exposing said internucleotide bond to an oxidizing agent.

10 . The method according to claim 8 , wherein said method further comprises removing said thiocarbon protecting group.

11 . The method according to claim 8 , wherein said nucleoside residue is covalently bound to a solid support.

12 . The method according to claim 11 , wherein said method further comprises cleaving said nucleic acid from said solid support to produce a free nucleic acid.

13 . The method according to claim 8 , wherein the thiocarbon protecting group is selected from the group of structures consisting of:

14 . The method according to claim 13 , wherein the thiocarbon protecting group is

and wherein each of R 1 or R 2 is independently selected from the group consisting of 4,4′-dimethoxytrityl (DMT) and 2-cyanoethyl-(N,N-diisopropylamine)-phosphoramidite.

15 . The method according to claim 14 , wherein Q is G or C.

16 . The method according to claim 15 , wherein Q is G.

17 . A protected nucleic acid comprising the structure of Formula VIII:

wherein R 3 is H, F, O—C 1-6 alkyl, O-MOE, or O-thiocarbon protecting group;

wherein Q is a heterocyclic base;

wherein R 4 is cyclopentyl or cyclohexyl;

wherein R 5 is selected from the group consisting of hydrogen, a hydrocarbyl, a substituted hydrocarbyl, an aryl, and a substituted aryl; and

wherein m is an integer of at least 1.

18 . The protected nucleic acid of claim 17 , wherein Q is G, wherein said thiocarbon protecting group is:

said R 4 is cyclopentyl, and said R 5 is 2-cyanoethyl or methyl.